COVID-19 Poses Significant Risks to Pregnant Women and Their Fetuses
Pregnant women with symptomatic COVID-19 face 2-3 fold higher risks of ICU admission, invasive ventilation, and death compared to symptomatic non-pregnant women of reproductive age, with the greatest dangers occurring in the third trimester. 1
Maternal Risks
Severe Disease and Mortality
Symptomatic pregnant women experience substantially elevated risks compared to their non-pregnant counterparts 1:
- ICU admission: 10.5% vs 3.9% (Risk Ratio 3.0)
- Invasive ventilation: 2.9% vs 1.1% (Risk Ratio 2.9)
- Death rates: Particularly elevated in women >35 years with comorbidities
The third trimester carries the highest mortality burden, with maternal deaths reaching 24.2% in this period compared to essentially no deaths in the first trimester and 4% in the second trimester 2. Hospitalization duration also increases significantly in the third trimester (10.1 days vs 4.0 days in first trimester) 2.
Pregnancy-Specific Complications
COVID-19 infection during pregnancy increases the odds of 3:
- Preeclampsia/eclampsia: adjusted OR 1.57 (95% CI 1.44-1.72)
- Preterm delivery: adjusted OR 2.17 (95% CI 1.96-2.42)
- Fetal death: adjusted OR 2.21 (95% CI 1.58-3.11)
Additional complications include higher rates of myocardial infarction, venous thromboembolism, and increased need for chest imaging and mechanical ventilation 4.
High-Risk Groups
Risk is amplified in pregnant women with 1:
- Age >35 years
- Obesity
- Diabetes
- Cardiovascular disease
- Chronic lung disease
- Black, Asian, or Hispanic ethnicity
Fetal and Neonatal Risks
Adverse Pregnancy Outcomes
COVID-19 infection significantly impacts fetal outcomes 5:
- Increased risk of fetal death (statistically significant)
- Increased premature delivery (statistically significant)
- NICU admission: 25% of neonates born to COVID-19 positive mothers require NICU care 4
- Preterm birth: Spontaneous preterm birth rate of 6% 4
Interestingly, the meta-analysis found a lower risk of miscarriage in COVID-19 patients compared to controls, possibly due to enhanced prenatal surveillance 5.
Cesarean Section Rates
The cesarean section rate is substantially elevated, ranging from 67.2% to 94% in COVID-19 infected mothers 4.
Vertical Transmission
Vertical transmission remains relatively uncommon. Limited evidence shows that while ACE2 receptors (the viral entry point) are present on placental syncytiotrophoblast cells, actual transmission to neonates occurs in only approximately 4.5% of cases 4, 6.
Mechanism of Increased Risk
Physiologic Vulnerability
Pregnancy creates a perfect storm for COVID-19 severity 4:
ACE2 receptor upregulation: Normal pregnancy increases ACE2 receptor expression, which SARS-CoV-2 uses for cell entry. Once the virus binds, it downregulates ACE2, leading to:
- Vascular dysfunction
- Endothelial cell damage
- Microcirculatory dysfunction
- Vasoconstriction
- Increased risk of miscarriages, premature births, and intrauterine growth restriction
Hypercoagulable state: COVID-19 exacerbates pregnancy's natural hypercoagulability, increasing risks of:
- Deep vein thrombosis
- Pulmonary embolism
- Stroke
Immune and physiologic changes: Pregnancy-related alterations in immune activity, cardiovascular and respiratory physiology make pregnant women more susceptible to severe respiratory illness 4.
Clinical Severity Distribution
Among COVID-19 positive pregnant women 6:
- Asymptomatic: 79.5% (though other studies report 43.5-92% when universal testing is available 4)
- Mild illness: 16%
- Moderate illness: 4.5%
- Severe illness: Up to 18% 4
- Critical disease: Up to 5% 4
Common Symptoms
The most frequent COVID-19 symptoms in pregnancy include 2:
- Myalgia (24.8%)
- Cough (19.3%)
- Fever (17.5%)
- Olfactory disorder (14.3%)
Post-COVID Sequelae
Long-term symptoms are more prevalent when infection occurs during the third trimester 2:
- Persistent loss of smell
- Dry eyes
- Post-partum depression
- Knee pain
- Myalgia
Critical Caveat: Trimester-Specific Risks
The timing of infection matters profoundly. Third-trimester infections carry the worst prognosis for both maternal and fetal outcomes 2. Fetal condition is most favorable when maternal infection occurs in the first trimester (92.9% good outcomes) compared to second (80%) or third trimester (66.7%), though these differences did not reach statistical significance 2.
Vaccination Imperative
COVID-19 vaccination is strongly recommended for all pregnant women 3, 7. The CDC recommends vaccination for all people aged 12 years and older, including those who are pregnant, breastfeeding, or planning pregnancy 3. mRNA vaccines (Pfizer/BioNTech and Moderna) are specifically prioritized for pregnant women 7, 4.
Vaccination data shows no increased risk of spontaneous abortion: among 2,456 pregnant persons receiving mRNA vaccines preconception or before 20 weeks, the cumulative risk of spontaneous abortion was 14.1%, within the expected range for recognized pregnancies 4.